Adaptive Control of Artificial Pancreas Systems - A Review

Artificial pancreas (AP) systems offer an important improvement in regulating blood glucose concentration for patients with type 1 diabetes, compared to current approaches. AP consists of sensors, control algorithms and an insulin pump. Different AP control algorithms such as proportional-integral-d...

Full description

Bibliographic Details
Main Authors: Kamuran Turksoy, Ali Cinar
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Journal of Healthcare Engineering
Online Access:http://dx.doi.org/10.1260/2040-2295.5.1.1
id doaj-83a4b72eda794e6f9abb6d27ff4c6a31
record_format Article
spelling doaj-83a4b72eda794e6f9abb6d27ff4c6a312020-11-24T20:54:31ZengHindawi LimitedJournal of Healthcare Engineering2040-22952014-01-015112210.1260/2040-2295.5.1.1Adaptive Control of Artificial Pancreas Systems - A ReviewKamuran Turksoy0Ali Cinar1Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USADepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USAArtificial pancreas (AP) systems offer an important improvement in regulating blood glucose concentration for patients with type 1 diabetes, compared to current approaches. AP consists of sensors, control algorithms and an insulin pump. Different AP control algorithms such as proportional-integral-derivative, model-predictive control, adaptive control, and fuzzy logic control have been investigated in simulation and clinical studies in the past three decades. The variability over time and complexity of the dynamics of blood glucose concentration, unsteady disturbances such as meals, time-varying delays on measurements and insulin infusion, and noisy data from sensors create a challenging system to AP. Adaptive control is a powerful control technique that can deal with such challenges. In this paper, a review of adaptive control techniques for blood glucose regulation with an AP system is presented. The investigations and advances in technology produced impressive results, but there is still a need for a reliable AP system that is both commercially viable and appealing to patients with type 1 diabetes.http://dx.doi.org/10.1260/2040-2295.5.1.1
collection DOAJ
language English
format Article
sources DOAJ
author Kamuran Turksoy
Ali Cinar
spellingShingle Kamuran Turksoy
Ali Cinar
Adaptive Control of Artificial Pancreas Systems - A Review
Journal of Healthcare Engineering
author_facet Kamuran Turksoy
Ali Cinar
author_sort Kamuran Turksoy
title Adaptive Control of Artificial Pancreas Systems - A Review
title_short Adaptive Control of Artificial Pancreas Systems - A Review
title_full Adaptive Control of Artificial Pancreas Systems - A Review
title_fullStr Adaptive Control of Artificial Pancreas Systems - A Review
title_full_unstemmed Adaptive Control of Artificial Pancreas Systems - A Review
title_sort adaptive control of artificial pancreas systems - a review
publisher Hindawi Limited
series Journal of Healthcare Engineering
issn 2040-2295
publishDate 2014-01-01
description Artificial pancreas (AP) systems offer an important improvement in regulating blood glucose concentration for patients with type 1 diabetes, compared to current approaches. AP consists of sensors, control algorithms and an insulin pump. Different AP control algorithms such as proportional-integral-derivative, model-predictive control, adaptive control, and fuzzy logic control have been investigated in simulation and clinical studies in the past three decades. The variability over time and complexity of the dynamics of blood glucose concentration, unsteady disturbances such as meals, time-varying delays on measurements and insulin infusion, and noisy data from sensors create a challenging system to AP. Adaptive control is a powerful control technique that can deal with such challenges. In this paper, a review of adaptive control techniques for blood glucose regulation with an AP system is presented. The investigations and advances in technology produced impressive results, but there is still a need for a reliable AP system that is both commercially viable and appealing to patients with type 1 diabetes.
url http://dx.doi.org/10.1260/2040-2295.5.1.1
work_keys_str_mv AT kamuranturksoy adaptivecontrolofartificialpancreassystemsareview
AT alicinar adaptivecontrolofartificialpancreassystemsareview
_version_ 1716794296123785216